|
V56763
|
F7H inhibitor
|
897109-93-2 |
F7H is a Frizzled receptor FZD7 antagonist (IC50= 1.25 μM). |
|
V56654
|
FAPI-4
|
2374782-02-0 |
FAPI-4 is a quinoline-based theranostic ligand targeting fibroblast activating protein. |
|
V56601
|
Feruloyltyramine
|
65646-26-6 |
Ferulamide is extracted from cannabis seeds, roots, leaves, and resin; causes hypothermia and uncoordinated movements in mice; moupinamide is the (E)-isomer. |
|
V56658
|
Fmoc-Cit-PABA
|
870487-04-0 |
Fmoc-Cit-PABA is a bioactive peptide linker that can be used for drug conjugate synthesis or ADC synthesis. |
|
V56643
|
FR054
|
35954-65-5 |
FR054 is an inhibitor (blocker/antagonist) of the hexosamine biosynthetic pathway (HBP) enzyme PGM3 and has significant anti-breast cancer effects. |
|
V56596
|
Gcase activator 2
|
2759897-35-1 |
Gcase activator 2 (compound 14) is a pyrrole[2,3-b]pyrazine and a β-glucocerebrosidase (Gcase) activator (EC50=3.8 μM). |
|
V56584
|
GFP16
|
749212-56-4 |
GFP16 is a low-affinity antiprion compound. |
|
V56661
|
GPAT-IN-1
|
1204347-51-2 |
GPAT-IN-1 is a glycerol 3-phosphate acyltransferase (GPAT) inhibitor (antagonist) with IC50 of 8.9 μM. |
|
V56687
|
GSK251
|
2125968-05-8 |
GSK251 is a highly efficient, selective, orally bioavailable PI3Kδ inhibitor (antagonist) with a novel binding mode. |
|
V56589
|
GSK3β Inhibitor II
|
478482-75-6 |
GSK3β inhibitor II is an inhibitor (blocker/antagonist) of GSK3β. |
|
V56712
|
GW438014 free base
|
469861-48-1 |
GW438014A is a selective NPY-Y5 receptor antagonist. |
|
V56812
|
GW590735
|
622402-22-6 |
GW590735 is a potent and specific PPARα agonist/activator with EC50 of 4 nM for expressing a GAL4-responsive reporter gene and is at least 500-fold more selective than PPARγ and PPARδ. |
|
V56583
|
GW6340
|
405910-78-3 |
GW6340 is a gut-specific LXR agonist. |
|
V56653
|
h-NTPDase8-IN-1
|
716358-51-9 |
h-NTPDase8-IN-1 (compound 2d) is a sulfamoylbenzamide-based selective inhibitor of h-NTPDases8 (IC50=0.28 μM). |
|
V56746
|
HaloPROTAC3
|
1799506-07-2 |
HaloPROTAC3 is a degrader of HaloTag fusion proteins. |
|
V56580
|
hCAII-IN-8
|
952306-80-8 |
hCAII-IN-8 is an amide and a selective carbonic anhydrase (CA) inhibitor (antagonist) with IC50 of 0.18 μM for hCA II. |
|
V56808
|
hCAII-IN-9
|
2878477-18-8 |
hCAII-IN-9 is a potent carbonic anhydrase inhibitor (antagonist) with IC50s of 1.18 μM (hCA II), 0.17 μM (hCA IX), and 2.99 μM (hCA XII). |
|
V56585
|
HG106
|
928712-10-1 |
HG106 is a potent SLC7A11 inhibitor. |
|
V56695
|
HHS-0701
|
2851993-91-2 |
HHS-0701 is a sulfur triazole exchange (SuTEx) ligand and a potent inhibitor of tyrosine-responsive prostaglandin reductase 2 (PTGR2). |
|
V51975
|
HP661
|
2938220-60-9 |
HP661 is an orally bioactive oxidative phosphorylation (OXPHOS) inhibitor that can effectively block the activity of mitochondrial complex I and reduce the production of reactive oxygen species. |